These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2528460

  • 1. Bispecific F (ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells.
    Nitta T, Yagita H, Azuma T, Sato K, Okumura K.
    Eur J Immunol; 1989 Aug; 19(8):1437-41. PubMed ID: 2528460
    [Abstract] [Full Text] [Related]

  • 2. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
    Tutt A, Stevenson GT, Glennie MJ.
    J Immunol; 1991 Jul 01; 147(1):60-9. PubMed ID: 1675655
    [Abstract] [Full Text] [Related]

  • 3. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    Glennie MJ, McBride HM, Worth AT, Stevenson GT.
    J Immunol; 1987 Oct 01; 139(7):2367-75. PubMed ID: 2958547
    [Abstract] [Full Text] [Related]

  • 4. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA, June CH, Martin PJ, Spooner CE, Hansen JA, Meier KE.
    J Immunol; 1986 Jun 01; 136(11):3945-52. PubMed ID: 3084650
    [Abstract] [Full Text] [Related]

  • 5. Target cell-induced T cell activation with bi- and trispecific antibody fragments.
    Jung G, Freimann U, Von Marschall Z, Reisfeld RA, Wilmanns W.
    Eur J Immunol; 1991 Oct 01; 21(10):2431-5. PubMed ID: 1655465
    [Abstract] [Full Text] [Related]

  • 6. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 7. [Bi-specific F(ab')2 enhances cytolytic activities of LAK cells against human small cell lung cancer (SCLC)].
    Azuma A, Niitani H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep 01; 29(9):1132-7. PubMed ID: 1661346
    [Abstract] [Full Text] [Related]

  • 8. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
    Chapoval AI, Nelson H, Thibault C.
    J Immunol; 1995 Aug 01; 155(3):1296-303. PubMed ID: 7636196
    [Abstract] [Full Text] [Related]

  • 9. Bispecific F(ab'gamma)3 antibody derivatives for redirecting unprimed cytotoxic T cells.
    Tutt A, Greenman J, Stevenson GT, Glennie MJ.
    Eur J Immunol; 1991 Jun 01; 21(6):1351-8. PubMed ID: 1828423
    [Abstract] [Full Text] [Related]

  • 10. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H, Ramsey PS, Kerr LA, McKean DJ, Donohue JH.
    J Immunol; 1990 Nov 15; 145(10):3507-15. PubMed ID: 1700013
    [Abstract] [Full Text] [Related]

  • 11. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
    Scott CF, Bolender S, McIntyre GD, Holldack J, Lambert JM, Venkatesh YP, Morimoto C, Ritz J, Schlossman SF.
    J Immunol; 1989 Jun 01; 142(11):4105-12. PubMed ID: 2565930
    [Abstract] [Full Text] [Related]

  • 12. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
    Scheffold C, Kornacker M, Scheffold YC, Contag CH, Negrin RS.
    Cancer Res; 2002 Oct 15; 62(20):5785-91. PubMed ID: 12384539
    [Abstract] [Full Text] [Related]

  • 13. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML, Shalaby MR, Werther W, Presta L, Carter P.
    Int J Cancer Suppl; 1992 Oct 15; 7():45-50. PubMed ID: 1428403
    [Abstract] [Full Text] [Related]

  • 14. Formation of a bispecific antibody by the use of leucine zippers.
    Kostelny SA, Cole MS, Tso JY.
    J Immunol; 1992 Mar 01; 148(5):1547-53. PubMed ID: 1531669
    [Abstract] [Full Text] [Related]

  • 15. [The enhancement of cytolytic activity in lymphokine activated killer cells using bispecific F(ab')2].
    Azuma A.
    Nihon Ika Daigaku Zasshi; 1991 Dec 01; 58(6):663-72. PubMed ID: 1663120
    [Abstract] [Full Text] [Related]

  • 16. Induction of cytotoxicity in human T cells coated with anti-glioma x anti-CD3 bispecific antibody against human glioma cells.
    Nitta T, Sato K, Okumura K, Ishii S.
    J Neurosurg; 1990 Mar 01; 72(3):476-81. PubMed ID: 2137533
    [Abstract] [Full Text] [Related]

  • 17. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S, Giudizi MG, Biagiotti R, Almerigogna F, Maggi E, Del Prete G, Ricci M.
    J Immunol; 1981 Oct 01; 127(4):1307-13. PubMed ID: 6974188
    [Abstract] [Full Text] [Related]

  • 18. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T, Nakamura Y, Takeuchi Y, Tokuda Y, Iwasawa M, Kawasaki A, Okumura K, Habu S.
    J Immunol; 1992 Jan 01; 148(1):285-91. PubMed ID: 1345787
    [Abstract] [Full Text] [Related]

  • 19. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA.
    J Immunol; 1991 Sep 01; 147(5):1492-503. PubMed ID: 1831826
    [Abstract] [Full Text] [Related]

  • 20. CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro.
    Molema G, Tervaert JW, Kroesen BJ, Helfrich W, Meijer DK, de Leij LF.
    Br J Cancer; 2000 Jan 01; 82(2):472-9. PubMed ID: 10646907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.